Does long-term survival exist in pancreatic adenocarcinoma?-Reference-Cited by-同舟云学术

Does long-term survival exist in pancreatic adenocarcinoma?

Published:2015-11-11 Issue:3 Volume:55 Page:259-264
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Zijlstra Myrte¹,Bernards Nienke¹²,de Hingh Ignace H. J. T.³,van de Wouw Agnes J.⁴,Goey Swan Hoo⁵,Jacobs Esther M. G.⁶,Lemmens Valery E. P. P.²⁷,Creemers Geert-Jan¹

Affiliation:

1. Department of Internal Medicine, Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands;

2. The Netherlands Cancer Registry, Comprehensive Cancer Organization the Netherlands, Utrecht, The Netherlands;

3. Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands;

4. Department of Internal Medicine, Medical Oncology, VieCuri Medical Center, Venlo, The Netherlands;

5. Department of Internal Medicine, Medical Oncology, TweeSteden Hospital, Tilburg, The Netherlands;

6. Department of Internal Medicine, Medical Oncology, Elkerliek Hospital, Helmond, The Netherlands;

7. Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1096020

Reference23 articles.

1. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

2. Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

4. The relevance of pathological verification in suspected pancreatic cancer

5. Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965–2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications;Biomedicines;2023-06-15

2. ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer;Aging;2022-10-08

3. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer;International Journal of Molecular Sciences;2021-10-10

4. Recent advances and prospects in gemcitabine drug delivery systems;International Journal of Pharmaceutics;2021-01

5. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma;Clinical and Translational Oncology;2020-05-23